Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals
- PMID: 7697276
- DOI: 10.1164/ajrccm.151.4.7697276
Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals
Abstract
To test the hypothesis that a Pseudomonas aeruginosa flagella (FLA) vaccine, intramuscularly administered, elicits specific antibodies in the respiratory tract, antibody titers against FLA were determined in sera and bronchoalveolar lavage (BAL) fluids of 10 healthy human adults before and after immunization. Immunization produced significantly increased anti-FLA antibody titers in all sera (mean reciprocal titers: IgG: 26,711; IgA: 2,767; IgM: 421) and on respiratory epithelial lining fluids (mean reciprocal titers: IgG: 112; IgA: 76; sIgA: 26). Significant differences in class-specific serum and BAL anti-FLA titers suggested airway antibody production. The study shows that parenteral immunization provides not only high systemic antibody titers but also local antibody production in the human respiratory tract.
Similar articles
-
Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.Respir Res. 2007 Aug 5;8(1):57. doi: 10.1186/1465-9921-8-57. Respir Res. 2007. PMID: 17683588 Free PMC article. Clinical Trial.
-
A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.Behring Inst Mitt. 1997 Feb;(98):338-44. Behring Inst Mitt. 1997. PMID: 9382758 Clinical Trial.
-
Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.APMIS. 1991 Dec;99(12):1061-8. APMIS. 1991. PMID: 1772641
-
Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers.Vaccine. 2010 Jan 8;28(3):707-13. doi: 10.1016/j.vaccine.2009.10.080. Epub 2009 Nov 1. Vaccine. 2010. PMID: 19887136
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
Cited by
-
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients.Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11020-5. doi: 10.1073/pnas.0702403104. Epub 2007 Jun 21. Proc Natl Acad Sci U S A. 2007. PMID: 17585011 Free PMC article. Clinical Trial.
-
Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.PLoS One. 2018 Sep 6;13(9):e0203143. doi: 10.1371/journal.pone.0203143. eCollection 2018. PLoS One. 2018. PMID: 30188914 Free PMC article.
-
Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.Clin Diagn Lab Immunol. 1997 Sep;4(5):499-503. doi: 10.1128/cdli.4.5.499-503.1997. Clin Diagn Lab Immunol. 1997. PMID: 9302194 Free PMC article.
-
Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia.Infect Immun. 2021 Jan 19;89(2):e00451-20. doi: 10.1128/IAI.00451-20. Print 2021 Jan 19. Infect Immun. 2021. PMID: 33199354 Free PMC article.
-
The impact of human vaccines on bacterial antimicrobial resistance. A review.Environ Chem Lett. 2021;19(6):4031-4062. doi: 10.1007/s10311-021-01274-z. Epub 2021 Sep 29. Environ Chem Lett. 2021. PMID: 34602924 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous